address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,hasPrePostMarketData,firstTradeDateMilliseconds,marketState,regularMarketPrice,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,regularMarketChangePercent,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,shortName,longName,trailingPegRatio
"Galaxy, Plot No. 1","22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt",Hyderabad,500032,India,91 40 6672 5000,91 40 6707 4044,https://www.aurobindo.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.","[{'maxAge': 1, 'name': 'Mr. Kambam Nithyananda Reddy', 'age': 66, 'title': 'Vice Chairman & MD', 'yearBorn': 1958, 'fiscalYear': 2024, 'totalPay': 45048542, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mettu Madan Mohan Reddy', 'age': 64, 'title': 'Whole-Time Director', 'yearBorn': 1960, 'fiscalYear': 2024, 'totalPay': 60146196, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Makkapati  Satakarni B.E., M.B.A., Ph.D.', 'age': 43, 'title': 'President of Biologics, CEO of Biologics, Vaccines and Peptid & Director', 'yearBorn': 1981, 'fiscalYear': 2024, 'totalPay': 300000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Santhanam  Subramanian', 'age': 63, 'title': 'Chief Financial Officer', 'yearBorn': 1961, 'fiscalYear': 2024, 'totalPay': 21060000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. S. Vijaya Kumar', 'age': 58, 'title': 'President of Technical', 'yearBorn': 1966, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. B. Adi Reddy', 'title': 'Compliance Officer & Company Secretary', 'fiscalYear': 2024, 'totalPay': 4760000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. G. P. Prasad', 'title': 'Senior Vice President of Global Finance & Operations', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sudhir Bimal Singhi', 'age': 55, 'title': 'Head of Global Finance Operations', 'yearBorn': 1969, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. A. Rama Mohana Rao', 'age': 62, 'title': 'Chief Quality Officer -Corporate QA', 'yearBorn': 1962, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. V. K. Handa', 'age': 72, 'title': 'President of Chemical Research', 'yearBorn': 1952, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",9,4,1,1,2,1748736000,1735603200,[],86400,2,1082.5,1087.9,1081.0,1103.0,1082.5,1087.9,1081.0,1103.0,4.5,0.4,1708387200,0.0,0.66,0.217,18.329433,17.614384,2471266,2471266,1351875,1022394,1022394,0.0,0.0,0,0,637255876608,1010.0,1592.0,2.0087671,1174.926,1245.0455,0.0,0.0,INR,False,628748517376,0.10988,272817747,580801984,0.5426,0.28941,580801984,562.371,1.9510252,1743379200,1774915200,1743379200,-0.006,34858799104,59.86,62.29,2:1,1437350400,1.982,9.519,-0.12778986,0.094471335,1.5,1708387200,EQUITY,1097.2,1930.0,1100.0,1403.2963,1400.0,1.85185,buy,27,82355003392,141.836,66054397952,82628698112,0.952,1.85,317237297152,25.31,544.309,0.06531,0.11148,186974896128,11753175040,39246200832,0.003,0.106,0.58938,0.20822,0.16076,INR,AUROPHARMA.NS,en-US,US,Equity,Delayed Quote,True,HIGH,False,821677500000,POSTPOST,1097.2,14.699951,1081.0 - 1103.0,NSE,1351875,87.19995,0.08633658,1010.0 - 1592.0,-494.80005,-0.31080404,-12.778986,1748257140,1754650740,1755000000,1748314800,1748314800,True,59.86,62.29,69.49333,15.788565,-77.726074,-0.06615402,-147.84558,-0.11874713,15,15,1.9 - Buy,False,1.3579631,[],1750413599,NSI,finmb_1514127,Asia/Kolkata,IST,19800000,in_market,False,AUROBINDO PHARMA LTD,Aurobindo Pharma Limited,
